PORTFOLIO HIGHLIGHTS:
EpiBone, an HBSAANY portfolio company, is a biotechnology company spun out of Columbia University that grows personalized, living, and precise bone and cartilage grafts using stem cells and 3D design. Using proprietary technology, EpiBone grows personalized grafts that promote tissue regeneration and restore biological and mechanical functions. Nina Tandon, CEO of EpiBone, said "HBSAANY has been a critical part of EpiBone's ongoing success. They have invested with us over our two most recent rounds of funding, and the members are not only engaged financially, but are also actively involved in lending their expertise to our cause, as well as offering access to their respective networks. Brett Oberman and Julio Marquez have been the best champions we could have asked for, and we are so grateful to all the HBSAANY members who are now a part of the EpiBone family."
Front Range Biosciences, an HBSAANY portfolio company, is the leader in agricultural biotech for hemp, cannabis, and coffee. FRB breeds new varieties with crucial traits, then replicates them into millions of plants per year
Nick Hofmeister, Chief Strategic Officer and Co-Founder of FRB, said “HBSAANY has been with us since our earliest round of funding more than 3 years ago. They have been our biggest supporters, not only financially, but with customer and partner introductions. Barbara Moore, my HBSAANY Mentor, has also been an amazing mentor to me personally, through the inevitable rollercoaster of entrepreneurism. Would and have recommended her and HBSAANY to any other startup."
.jpg)
